lOMoAR cPSD| 32744169
TestkBankkforkIntroductorykClinicalkPharmacologyk12thkEditionkFor
d
Introductory Clinical Pharmacol
k k
ogy 12th Edition FordTest Bank
k k k k k
, lOMoAR cPSD| 32744169
TestkBankkforkIntroductorykClinicalkPharmacologyk12thkEditionkFor
d
1. Aknursingkinstructorkiskpreparingkakteachingkplankforkakgroupkofknursingkstudentskaboutkph
armacology.kWhenkdescribingkthisktopic,kthekinstructorkwouldkfocuskthekdiscussionkonkwh
ichkofkthekfollowingkaskankessentialkaspect?
A) Drugkname
B) Drugkclass
C) Drugkaction
D) Drugksourcek
Ans:k CkFeedbac
k:
Pharmacologykiskthekstudykofkdrugskandktheirkactionkonklivingkorganisms.kThus,kankess
entialkaspectkofkpharmacologykiskdrugkaction.kAnkunderstandingkofkthekdrugkname,kdru
gkclass,kandkdrugksourcekiskimportant,kbutkthekmostkcriticalkaspectkrelatedktokpharmacol
ogykiskhowkthekdrugkactskinkthekbody.
2. Aknursingkstudentkiskpreparingktokadministerkakprescribedkdrugktokakpatient.kThekstudentkre
viewskinformationkaboutkthekdrugkandkitskactions.kWhichkofkthekfollowingkwouldkbekthekbes
tkchoicekforkobtainingkthiskinformation?kSelectkallkthatkapply.
A) Nursingkinstructor
B) Nursekassignedktokthekpatient
C) Clinicalkdrugkreference
D) Prescribingkhealthkcarekprovider
E) Clinicalkpharmacistk
Ans:k C,kE
Feedback:
Althoughktheknursingkstudentkcankaskktheknursingkinstructor,ktheknursekassignedktokthekpati
ent,kandkthekprescribingkhealthkcarekproviderkforkinformationkaboutkthekdrug,kthekbestkchoi
ceskforkdrugkinformationkwouldkincludekankappropriatekdrugkreferencekandkthekclinicalkph
armacist.
3. Whenkdescribingkthekvariousktypeskofkmedicationsktokakgroupkofknursingkstudents,kakn
ursingkinstructorkwouldkidentifykwhichkofkthekfollowingkaskaksourcekforkderivingkme
dications?kSelectkallkthatkapply.
A) Plants
B) Syntheticksources
C) Mold
D) Minerals
E) AnimalskAns
:kA,kB,kC,kD,kEkFeed
back:
Medicationskarekderivedkfromknaturalksources,kforkexample,kplants,kmolds,kminerals,kandka
nimals,kaskwellkaskcreatedksyntheticallykinkaklaboratory.
Pagek 1
, lOMoAR cPSD| 32744169
TestkBankkforkIntroductorykClinicalkPharmacologyk12thkEditionkFor
d
4. Whichkofkthekfollowingknameskmaykbekassignedktokakdrugkduringkthekprocesskofkd
evelopment?kSelectkallkthatkapply.
A) Chemicalkname
B) Officialkname
C) Pharmacologickname
D) Tradekname
E) Nonproprietaryknamek
Ans:k A,kB,kD,kEkFeedback
:
Throughoutkthekprocesskofkdevelopment,kdrugskmaykhavekseveralknameskassignedktokthemk
includingkakchemicalkname,kakgenerick(nonproprietary)kname,kankofficialkname,kandkaktrade
korkbrandkname.
5. Akdrugkmaykbekclassifiedkbykwhichkofkthekfollowing?kSelectkallkthatkapply.
A) Thekchemicalktypekofkthekdrug'skactivekingredient
B) Thekwaykthekdrugkiskusedktoktreatkakspecifickcondition
C) Thekgenericknamekofkthekdrug
D) Thektradeknamekofkthekdrug
E) Theknonproprietaryknamekofkthekdrugk
Ans:k A,kB
Feedback:
Akdrugkmaykbekclassifiedkbykthekchemicalktypekofkthekactivekingredientkorkbykthekwaykitkisku
sedktoktreatkakparticularkcondition.kGeneric,ktrade,kandknonproprietarykreferktokhowkakdrugki
sknamed.
6. Akgroupkofknursingkstudentskarekreviewingkinformationkaboutkthekprocesskofkdrugkdeve
lopmentkinkthekUnitedkStates.kThekstudentskdemonstratekunderstandingkofkthiskprocessk
whenktheykidentifykthatkwhichkofkthekfollowingkcategorieskarekassignedkbykthekFoodkand
kDrugkAdministrationktoknewlykapprovedkdrugs? kSelectkallkthatkapply.
A) Metabolite
B) Noncontrolledksubstance
C) Prescription
D) Nonprescription
E) Controlledksubstancek
Ans:k C,kD,kE
Feedback:
Oncekdrugskarekapprovedkforkuse,kthekFDAkassignskthekdrugktokonekofkthekfollowingkcate
gories:kprescription,knonprescription,korkcontrolledksubstance.kMetabolitekrefersktoktheki
nactivekformkofkthekdrug.kNoncontrolledksubstancekiskaktermkthatkisknotkused.
Pagek 2
, lOMoAR cPSD| 32744169
TestkBankkforkIntroductorykClinicalkPharmacologyk12thkEditionkFor
d
7. Whichkofkthekfollowingkwouldkbekmostkimportantkforktheknursektokdoktokensurektheksafeku
sekofkprescriptionkdrugskinkthekinstitutionalksetting?kSelectkallkthatkapply.
A) Administeringkdrugs
B) Monitoringkclientskforkdrugkeffects
C) Prescribingkdrugs
D) Evaluatingkclientskforktoxickeffects
E) Educatingkclients/caregiverskaboutkdrugsk
Ans:k A,kB,kD,kE
Feedback:
Inkthekinstitutionalksetting,ktheknurse'skrolektokensureksafekusekofkprescriptionkdrugskinclu
deskadministeringkdrugs,kmonitoringkdrugkeffects,kevaluatingkforktoxickeffects,kandkeduca
tingkclientskandkcaregiverskaboutkdrugs.
8. Theknursekiskhelpingkakclientkreviewkakprescriptionkfromkthekhealthkcarekprovider.kWhenke
xaminingkthekprescription,kwhichkofkthekfollowingkwouldktheknursekexpectktokfindkdocum
ented?kSelectkallkthatkapply.
A) Namekofkthekdrug
B) Dosagekofkthekdrug
C) Routekofkdrugkadministration
D) Timeskofkdrugkadministration
E) Licensedkprescriber'sksignaturek
Ans:k A,kB,kC,kD,kE
Feedback:
Thekprescriptionkmustkcontainkthekclient'skname,ktheknamekofkthekdrug,kthekdosage,kthek
methodkandktimeskofkadministration,kandktheksignaturekofktheklicensedkhealthkcarekprovi
derkprescribingkthekdrug.
9. Afterkteachingkakgroupkofknursingkstudentskaboutknonprescriptionkdrugs,ktheknursingkinstr
uctorkdetermineskthatkthekteachingkwasksuccessfulkwhenkthekstudentskidentifykwhichkofkth
ekfollowing?kSelectkallkthatkapply.
A) Theykrequirekaklicensedkhealthkcarekprovider'sksignature.
B) Theykarekreferredktokaskover-the-counterkdrugs.
C) Theykcankbektakenkwithoutkriskktokthekclient.
D) Theykhavekcertainklabelingkrequirements.
E) Theykshouldkbektakenkonlykaskdirectedkonktheklabel.k
Ans:k B,kD,kE
Feedback:
Nonprescriptionkdrugskarekoftenkreferredktokaskover-the-
counterk(OTC)kdrugs.kTheykdoknotkrequirekakprescriptionk(aklicensedkhealthkcarekprovider'
sksignature)kbutkdoknotkcomekwithoutkriskktokthekclient.kThekfederalkgovernmentkhaskimpos
edklabelingkrequirementskofkOTCkdrugskandktheykshouldkonlykbektakenkaskdirectedkonkthekl
abelkunlesskunderktheksupervisionkofkakhealthkcarekprovider.
Pagek 3
TestkBankkforkIntroductorykClinicalkPharmacologyk12thkEditionkFor
d
Introductory Clinical Pharmacol
k k
ogy 12th Edition FordTest Bank
k k k k k
, lOMoAR cPSD| 32744169
TestkBankkforkIntroductorykClinicalkPharmacologyk12thkEditionkFor
d
1. Aknursingkinstructorkiskpreparingkakteachingkplankforkakgroupkofknursingkstudentskaboutkph
armacology.kWhenkdescribingkthisktopic,kthekinstructorkwouldkfocuskthekdiscussionkonkwh
ichkofkthekfollowingkaskankessentialkaspect?
A) Drugkname
B) Drugkclass
C) Drugkaction
D) Drugksourcek
Ans:k CkFeedbac
k:
Pharmacologykiskthekstudykofkdrugskandktheirkactionkonklivingkorganisms.kThus,kankess
entialkaspectkofkpharmacologykiskdrugkaction.kAnkunderstandingkofkthekdrugkname,kdru
gkclass,kandkdrugksourcekiskimportant,kbutkthekmostkcriticalkaspectkrelatedktokpharmacol
ogykiskhowkthekdrugkactskinkthekbody.
2. Aknursingkstudentkiskpreparingktokadministerkakprescribedkdrugktokakpatient.kThekstudentkre
viewskinformationkaboutkthekdrugkandkitskactions.kWhichkofkthekfollowingkwouldkbekthekbes
tkchoicekforkobtainingkthiskinformation?kSelectkallkthatkapply.
A) Nursingkinstructor
B) Nursekassignedktokthekpatient
C) Clinicalkdrugkreference
D) Prescribingkhealthkcarekprovider
E) Clinicalkpharmacistk
Ans:k C,kE
Feedback:
Althoughktheknursingkstudentkcankaskktheknursingkinstructor,ktheknursekassignedktokthekpati
ent,kandkthekprescribingkhealthkcarekproviderkforkinformationkaboutkthekdrug,kthekbestkchoi
ceskforkdrugkinformationkwouldkincludekankappropriatekdrugkreferencekandkthekclinicalkph
armacist.
3. Whenkdescribingkthekvariousktypeskofkmedicationsktokakgroupkofknursingkstudents,kakn
ursingkinstructorkwouldkidentifykwhichkofkthekfollowingkaskaksourcekforkderivingkme
dications?kSelectkallkthatkapply.
A) Plants
B) Syntheticksources
C) Mold
D) Minerals
E) AnimalskAns
:kA,kB,kC,kD,kEkFeed
back:
Medicationskarekderivedkfromknaturalksources,kforkexample,kplants,kmolds,kminerals,kandka
nimals,kaskwellkaskcreatedksyntheticallykinkaklaboratory.
Pagek 1
, lOMoAR cPSD| 32744169
TestkBankkforkIntroductorykClinicalkPharmacologyk12thkEditionkFor
d
4. Whichkofkthekfollowingknameskmaykbekassignedktokakdrugkduringkthekprocesskofkd
evelopment?kSelectkallkthatkapply.
A) Chemicalkname
B) Officialkname
C) Pharmacologickname
D) Tradekname
E) Nonproprietaryknamek
Ans:k A,kB,kD,kEkFeedback
:
Throughoutkthekprocesskofkdevelopment,kdrugskmaykhavekseveralknameskassignedktokthemk
includingkakchemicalkname,kakgenerick(nonproprietary)kname,kankofficialkname,kandkaktrade
korkbrandkname.
5. Akdrugkmaykbekclassifiedkbykwhichkofkthekfollowing?kSelectkallkthatkapply.
A) Thekchemicalktypekofkthekdrug'skactivekingredient
B) Thekwaykthekdrugkiskusedktoktreatkakspecifickcondition
C) Thekgenericknamekofkthekdrug
D) Thektradeknamekofkthekdrug
E) Theknonproprietaryknamekofkthekdrugk
Ans:k A,kB
Feedback:
Akdrugkmaykbekclassifiedkbykthekchemicalktypekofkthekactivekingredientkorkbykthekwaykitkisku
sedktoktreatkakparticularkcondition.kGeneric,ktrade,kandknonproprietarykreferktokhowkakdrugki
sknamed.
6. Akgroupkofknursingkstudentskarekreviewingkinformationkaboutkthekprocesskofkdrugkdeve
lopmentkinkthekUnitedkStates.kThekstudentskdemonstratekunderstandingkofkthiskprocessk
whenktheykidentifykthatkwhichkofkthekfollowingkcategorieskarekassignedkbykthekFoodkand
kDrugkAdministrationktoknewlykapprovedkdrugs? kSelectkallkthatkapply.
A) Metabolite
B) Noncontrolledksubstance
C) Prescription
D) Nonprescription
E) Controlledksubstancek
Ans:k C,kD,kE
Feedback:
Oncekdrugskarekapprovedkforkuse,kthekFDAkassignskthekdrugktokonekofkthekfollowingkcate
gories:kprescription,knonprescription,korkcontrolledksubstance.kMetabolitekrefersktoktheki
nactivekformkofkthekdrug.kNoncontrolledksubstancekiskaktermkthatkisknotkused.
Pagek 2
, lOMoAR cPSD| 32744169
TestkBankkforkIntroductorykClinicalkPharmacologyk12thkEditionkFor
d
7. Whichkofkthekfollowingkwouldkbekmostkimportantkforktheknursektokdoktokensurektheksafeku
sekofkprescriptionkdrugskinkthekinstitutionalksetting?kSelectkallkthatkapply.
A) Administeringkdrugs
B) Monitoringkclientskforkdrugkeffects
C) Prescribingkdrugs
D) Evaluatingkclientskforktoxickeffects
E) Educatingkclients/caregiverskaboutkdrugsk
Ans:k A,kB,kD,kE
Feedback:
Inkthekinstitutionalksetting,ktheknurse'skrolektokensureksafekusekofkprescriptionkdrugskinclu
deskadministeringkdrugs,kmonitoringkdrugkeffects,kevaluatingkforktoxickeffects,kandkeduca
tingkclientskandkcaregiverskaboutkdrugs.
8. Theknursekiskhelpingkakclientkreviewkakprescriptionkfromkthekhealthkcarekprovider.kWhenke
xaminingkthekprescription,kwhichkofkthekfollowingkwouldktheknursekexpectktokfindkdocum
ented?kSelectkallkthatkapply.
A) Namekofkthekdrug
B) Dosagekofkthekdrug
C) Routekofkdrugkadministration
D) Timeskofkdrugkadministration
E) Licensedkprescriber'sksignaturek
Ans:k A,kB,kC,kD,kE
Feedback:
Thekprescriptionkmustkcontainkthekclient'skname,ktheknamekofkthekdrug,kthekdosage,kthek
methodkandktimeskofkadministration,kandktheksignaturekofktheklicensedkhealthkcarekprovi
derkprescribingkthekdrug.
9. Afterkteachingkakgroupkofknursingkstudentskaboutknonprescriptionkdrugs,ktheknursingkinstr
uctorkdetermineskthatkthekteachingkwasksuccessfulkwhenkthekstudentskidentifykwhichkofkth
ekfollowing?kSelectkallkthatkapply.
A) Theykrequirekaklicensedkhealthkcarekprovider'sksignature.
B) Theykarekreferredktokaskover-the-counterkdrugs.
C) Theykcankbektakenkwithoutkriskktokthekclient.
D) Theykhavekcertainklabelingkrequirements.
E) Theykshouldkbektakenkonlykaskdirectedkonktheklabel.k
Ans:k B,kD,kE
Feedback:
Nonprescriptionkdrugskarekoftenkreferredktokaskover-the-
counterk(OTC)kdrugs.kTheykdoknotkrequirekakprescriptionk(aklicensedkhealthkcarekprovider'
sksignature)kbutkdoknotkcomekwithoutkriskktokthekclient.kThekfederalkgovernmentkhaskimpos
edklabelingkrequirementskofkOTCkdrugskandktheykshouldkonlykbektakenkaskdirectedkonkthekl
abelkunlesskunderktheksupervisionkofkakhealthkcarekprovider.
Pagek 3
